Theme: Theme: For Awareness and Attention to Female Reproductive System

GYNECOLOGIC ONCOLOGY 2024

GYNECOLOGIC ONCOLOGY 2024

ME Conferences cordially invites all professionals and researchers from across the world to the "10th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics"  to discuss their respective scientific research. Take advantage of the opportunity to attend this outstanding colloquium in London, UK on June 27-28, 2024.

The GYNECOLOGIC ONCOLOGY 2024 is a global gathering of specialists that focuses on core knowledge and major advances in the ever-expanding field of gynaecology and obstetrics. The discussion about cutting-edge breakthroughs in gynaecology and women's health takes place on a global scale. Meeting significant individuals and learning about the most recent technological developments will be an incredible experience.

Why to attend?

Top academic professionals, scientists and research scholars will convene at Gynecologic Oncology 2024 to interact and share their practices and research discoveries on all aspects of gynaecology and obstetrics. It also provides scientists practitioners and professors with the best interdisciplinary forum for presenting and discussing the most recent novelties trends and concerns as well as the practical difficulties they have encountered and the solutions they have chosen in the field of gynaecology and obstetrics. The primary purpose of the conference is to educate medical experts in the field of gynaecology as well as the general public about healthy living for women throughout the world and to motivate them to act fast to promote it.

Target Audience?

  • Women’s Healthcare Students, Scientists and professors
  • Women’s health Care Researchers
  • Healthcare Faculty
  • Medical Colleges
  • Healthcare Associations and Societies
  • Gynaecologists
  • Surgeons
  • Oncologists
  • Radiologists
  • Scientists and Professors
  • Fertility Doctor
  • Researchers
  • Scientists
  • Health care experts
  • Nutritionists
  • Microbiologist
  • Physicians
  • Nurse practitioners
  • Health care analysts
  • Doctors
  • Academic researchers
  • Professors
  • Students
  • Research Institutes
  • Business delegates
  • Young Researchers
  • Advertising and Promotion Agency Executives
  • Professionals in media sector
  • NGO & Associations
  • Obstetrician
  • Medical & Pharmaceutical Companies

Track 1: Obstetrics and Gynecology

Obstetrics medicine or tocology and medicine is the therapeutic claim to fame that covers the strength of the female fertile framework epithelial duct, uterus, ovaries, and bosoms and includes the two subspecialties of tocology, covering physiological condition, labour, and the baby blues. and Obstetrics medicine, or tocology and medicine, is a therapeutic claim to fame that encompasses the power of the feminine fertile framework epithelial duct, uterus, or Postgraduate training programmes for the two fields are frequently combined, preparing the practising accoucheur medical specialist to think about the welfare of female fertile organs while also managing physiological conditions, though some specialists pursue subspecialty interests in one or the other.

Track 2: COVID-19 and Pregnancy

The impact of COVID infection on pregnancy is unknown due to a lack of clinical data. According to the information available, COVID-19 infection has a comparable effect on pregnant women as it does on non-pregnant people. However, the impact of this illness on labour is greater. Pregnancies in women with COVID-19 are more likely to result in premature labour. It is regarded as the main consequence of COVID-19 infection. According to the research, the human placenta may include components that aid in the spread of COVID-19.

  • Preterm labour
  • Human placenta
  • COVID-19 infection
  • Pregnancy
  • Non-pregnant adults

Track 3: Gynecological Surgeries

Gynaecological procedures are any operations performed by gynaecologists on the female reproductive system. These operations aid in the treatment of the tumour as well as other reproductive difficulties. These gynaecological operations may involve surgery on any part of the female reproductive system, including the ovaries, fallopian tubes, uterus, vagina, and vulva. The following are some instances of common gynaecological surgeries.

Track 4: Sub Specialties of Gynecology

Gynecologic oncology is a specialism concerned with the treatment of gynaecological cancers such as ovarian, endometrial, and cervical cancer. Maternal/Fetal Medicine is a specialisation that focuses on foetal anomalies and maternal health care. It also treats severe pregnancy problems. Reproductive Endocrinology and Infertility is a specialisation that focuses on managing infertility and other endocrine problems that influence the female reproductive system. Breast Disease is a subfield that focuses with the treatment of breast ailments. Paediatric gynaecology, often known as paediatric gynaecology, is a specialist that treats problems of the infant's vagina, uterus, and ovaries. There are several other sub branches, including

  • Female Reconstructive Pelvic Surgeon
  • Complex Family Planning surgeon
  • Minimally-Invasive Gynecologic Surgeon
  • Pediatric and Adolescent Gynecology
  • Global Women’s Health

Track 5: Advancements in Gynaecology and Obstetrics

Imaging technology, pharmaceutical therapy, endoscopic equipment, and reproductive technologies used in gynaecology and obstetrics have all evolved dramatically over time. Nowadays, all major gynaecological surgeries are being replaced with laparoscopic and hysteroscopy ablation procedures. The intrauterine progestogen releasing device is another advancement that can help with long-term menorrhagia treatment as well as contraception. Pharmaceutical advancements include gonadotropin-releasing hormone agonists and the treatment of male factor infertility.

  • Laparoscopy
  • Levonorgestrel intrauterine system
  • Progestogen
  • Contraception
  • Hysteroscopy

Track 6: Assisted Reproductive Technology

The primary medical treatment utilised in assisted reproductive technology for infertility. Medical methods involved include intracytoplasmic sperm injections, in vitro fertilisation, gamete cryopreservation, and fertility medication administration. Another assisted reproductive procedure is ovulation induction, which stimulates ovarian follicles by administering fertility medications while monitoring follicle size egg development, and reproductive hormone production. Once the eggs are ready the ovulation process is initiated with an HCG injection. Other treatments include gamete intrafallopian transfer and mitochondrial replacement therapy. There are extremely few male-specific infertility medications available ovulation induction.

  • In vitro fertilization
  • Cryopreservation
  • Mitochondrial replacement therapy
  • Human chronic gonadotropin
  • Intracytoplasmic sperm injections

Track 7: Infertility

Infertility is the inability of a person animal or plant to reproduce in a natural manner. Individually fruitlessness is defined as the inability to conceive after one year of intercourse without the assistance of a male and female partner. There are various causes of physiological illness, some of which can be cured with therapeutic intervention. For whatever reason, many couples remain in an autopilot state of affairs for at least a year. The most prevalent cause of female infertility is ovulation problems, which are characterised by irregular or missing menstrual periods. Male barrenness is most usually caused by a lack of humour, which is employed as a fertility surrogate.

  • Basal body temperature
  • Antisperm antibodies
  • Immune infertility
  • Syphilis
  • Gonorrhea
  • Immunoregulatory mechanism

Track 8: Poly Cystic Ovarian Syndrome

It is described as a clinical illness in which a woman's hormone levels fluctuate. It is distinguished by elevated levels of male hormones, resulting in hormonal irregularities and missed menstrual cycles. Pelvic ultrasonography is the most common way for finding it. The syndrome's name stems from the formation of many ovarian cysts which are immature follicles. Increased testosterone secretion, together with luteinizing hormone and elevated insulin levels, is the primary cause of PCOS development. One of the most common PCOS therapies is the combination of oral contraceptives and metformin.

  • Testosterone
  • Luteinizing hormone
  • Metformin
  • Sex hormone binding globulins
  • Oral contraceptives

Track 9: Pregnancy and Child Birth

The term "pregnancy" refers to the time when the foetus develops and grows within the mother's womb. This period normally lasts nine months, or forty weeks. There are three trimesters in a pregnancy. The first trimester lasts anywhere from one to twelve weeks. It is the stage in which a zygote transforms into a foetus from a collection of cells. The second trimester might last as long as 28 weeks. Ultrasonography can detect birth anomalies in the foetus at this point, and footprints appear, as the sleep-wake cycle begins. The third trimester can last for up to 40 weeks. Babies delivered in week 40 are considered fully term.

Track 10: Prenatal care Postnatal care

Prenatal care, also referred to as antepartum care, is a sort of preventative human service. It is most likely to give customary recording that allows change specialists or maternity specialists to treat and avoid potential medical problems as the physiological condition progresses, as well as to promote healthy lifestyles that benefit both the mother and the kid. Pregnant women are given medical information regarding maternal physiological changes, natural changes, pre-birth nourishment, and pre-birth nutrients when they register. Routine registration also generates proposals for executives and significant lifestyle changes. Postpartum thought refers to the thoughts that a woman and her infant have after birth and during the first month and a half of their life.

Track 11: Endocrine and Metabolic disorders in Pregnancy

Endocrine activity in the developing foetus is normally controlled by the mother with the embryo becoming less responsive to maternal hormones as the craniate organs form and grow throughout the trimester. An endocrine issue in physiological condition requires the professional to undergo a special examination. The physiological condition state can change illness signals, making it difficult to identify them from the typical hypermetabolic state of physiological condition. The mother's and the embryo's treatment demands may differ, necessitating a delicate balance act. Physiological state polygenic disorder, which is rapidly expanding, is caused by secretory changes across physiological states. Its key differentiating feature is articulated hypoglycemic agent blocking, although it has all the hallmarks of a complex approach with a variety of metabolic components when combined

Track 12: Perinatal Depression

Perinatal depression is a historical and essential notion that aids in the detection, treatment, and, if necessary, referral of affected girls to psychological well-being care. Family specialists learnt about risk factors for peripartum depression such as a history of depression, life events and interpersonal conflict. Perinatal depression has been related to a number of poor effects, including difficulties for the mother child and family unit. Babies and immature offspring of perinatally discouraged moms are more likely to have a difficult temperament, as well as psychological and cognitive delays.

Track 13: Family Planning

The term "Family Planning" refers to "informative comprehensive health or social activities that empower individuals including minors to make an unreserved decision about the number and division of their children and the methods by which this can be accomplished. Birth control may involve factors such as the number of children a woman need the option of not having children and the age at which she must have them. External factors such as dating conditions career considerations financial situation any handicaps that will limit their ability to own and raise children and a number of other considerations all contribute to these issues.

  • Contraceptive services
  • Pregnancy testing and counseling
  • Pregnancy–achieving services including preconception health services

Track 14: Cosmetic Gynecology

Following then ageing and events such as maternity and birth will affect the canal's inner and outer structure creating changes in both appearance and physical reaction to improvement. Cosmetic medicine tries to improve either the cosmetic appearance or the functionality of the canal and labia in most cases both goals are pursued simultaneously. The effects of cosmetic medical specialism will increase sexual exercise satisfaction while also restoring the crotch making the body appear younger or more deliciously rewarding. Cosmetic medicine has evolved as one of the most rapidly expanding elective procedures for women bringing together specialists in medicine  urogynecology, urology.

Track 15: Women and Mental Health

Women and men with associate's degrees will face unanticipated challenges due to mental problems. Women are increasingly experiencing a variety of challenges including melancholy and discomfort. Women are also inexperienced with different types of disarrays. Many women for example may develop mental issues as a result of internal secretion changes such as prenatal heart sickness emission distress and perimenopausal depression. There are no differences in the rates at which persons develop certain mental disorders including psychosis and bipolar disorder .

  • Infertility
  • Female Sterilization
  • Reproductive Tract

Track 16: Fetal and Maternal Medicine

Tocology sometimes known as maternal fetal medicine, is a specialty of medicine that deals with the mother's and child's eudaimonia problems before, during, and after pregnancy. Maternal foetal medications authorities are doctors who specialise in midwifery. They typically complete a four year residency in midwifery and medicine followed by a three-year partnership. They work as both a specialist in lower risk pregnancies and the principal specialist in significantly higher risk ones. When it comes to giving delivery they will work closely with paediatricians and neonatologists. Perinatologists assist moms in dealing with earlier eudaimonia concerns, despite the obstacles caused by pregnancy.

Track 17: Gynecology cancers  

Gynaecological malignancies are tumours that arise in a woman's reproductive tract. Cervical cancer is only one type of medical issue. Each of these cancers has a variety of risk factors including inherited ones. Despite the fact that it is possible many women develop cancer despite not being at high risk. It is vital for women to understand the various forms of medical specialist malignant growth side effects potential warning signs to check for as well as screening and prevention strategies.

Track 18: Surgical Gynocology: Procedures and Case Studies

The great majority of surgical medical procedures have advanced and are barely noticeable. These careful technologies will be used to treat a variety of medical conditions such as hysterectomies, infertility and the removal of troublesome fibroids. The most often utilised procedures are laparotomy, excision, and mechanical therapy. Endoscopy is used to treat mucosa ablation, fibroids and to prevent taking anti-conception medications indefinitely. Laparotomy is often performed to assess the condition of the womb's exterior for pathology fibroids and infertility treatment extraction and sanitation purposes.

Track 19: Reproductive Health, Fertility and Sexual Health

Reproductive health indicates that people will have a capable meaningful and safer sexual existence, which they must be able to repeat, allowing them to choose whether or not to do so once and how frequently. Individuals should be educated about and approach safe, strong, moderate, and appropriate anti-conception medication; also, access to proper social welfare administrations of sexual, regeneration drug, and utilisation of eudaimonia instruction begins to emphasise the need of ladies travelling firmly through physiological conditions, and childbirth may supply couples with the most obvious opportunity to have a patience. The term Sexual and Procreative Health appears to be most typically related with issues of rights.

Scope and Importance:

The goal of Gynaecologic Oncology 2024 is to convene leading specialists and delegates for a comprehensive conversation about women's health and gynaecology. Distinguished academics, students, and researchers from all areas of gynaecologists, Oncologists are invited to participate in this conference, which will function as a global forum for the exchange of cutting-edge concepts, creative ideas, and real-world development experiences.

Gynecology Drugs Global Market

The market for gynaecology medications is made up of companies (organisations and partnerships) that sell gynaecology drugs. These drugs are used to treat gynaecological diseases, which include ailments that affect the uterus, ovaries, and their appendages. Few gynaecological diseases have advanced to the clinical trial stage, despite the fact that drug makers are investing in the development of personalised cancer vaccines. In 2021, the market for gynaecology pharmaceuticals was dominated by North America. Throughout the projection period, Asia Pacific is expected to grow at the fastest rate. The gynaecology medicines market research encompasses the following regions: Africa, North America, South America, Middle East, Asia-Pacific, and Western and Eastern Europe.

Gynecological Cancers Therapeutics Market: Current Analysis and Forecast (2023-2030)

The global market for therapies for gynaecological cancers was estimated to be worth USD 3.2 billion in 2022. From 2023 to 2030, it is expected to increase at a compound annual growth rate (CAGR) of 6.5%, reaching USD 8.2 billion. Gynaecological cancer cases have increased worldwide, which has led to a rise in the need for gynaecological cancer treatments services. This motivating element has caused the market to rise significantly. Furthermore, government awareness campaigns about gynaecological cancers and spending in oncology departments have grown dramatically in recent years, which is one of the main drivers driving market potential.

Thanks to all of our amazing keynote speakers, presenters, conference attendees, students, associations, media partners, and visitors GYNECOLOGIC ONCOLOGY 2023 was a huge success. The " 9th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics on December 11-12, 2023 at Rome, Italy was a big success thanks to Conference Series. The audience heard from renowned keynote speakers who represented a variety of prestigious organisations and groups. Renowned experts, members of the Editorial Board of journals in the Conference series, students, research scholars, scientists, young researchers, industrialists, endocrinologists, doctors, gynaecological oncologists, and student researchers all generously and actively participated and helped make the event a success. A ceremony and speeches by the Keynote forum speakers marked the beginning of the conference. The experts who spread the message with their beautiful talk were. Let's reconnect @ GYNECOLOGIC ONCOLOGY 2024

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 27-28, 2024
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View